ARCHIVES

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

March 27, 1981

Survey Commissioned By Cancer Control Program Finds Important RMP Effort Being Phased Out

July 19, 1974

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013